Compliance with national guidelines in patients with diabetes in a family practice clinic

Pharmacotherapy

Volumn 22, Issue 12 I, 2002, Pages 1541-1546

  Kirk, Julienne K ^a   Poirier, Jessica E ^b   Mattox, Michelle G ^c   Thomas, Perry M ^a   Michielutte, Robert ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ROSIGLITAZONE; SULFONYLUREA; TROGLITAZONE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FAMILY MEDICINE; FEMALE; GENERAL PRACTICE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; HYPERLIPIDEMIA; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIMARY PREVENTION; SECONDARY PREVENTION; SYSTOLIC BLOOD PRESSURE; TREATMENT PLANNING;

EID: 0036896729     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.17.1541.34119     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. Facts About Cardiovascular Disease. Available from http://www.cdc.gov/od/oc/media/fact/cardiova.htm. Accessed October 7, 2002.
2. Centers for Disease Control and Prevention. Diabetes. Available from http://www.cdc.gov/od/oc/media/fact/diabetes.htm. Accessed October 7, 2002.
3. Egede LE, Zheng D. Modifiable cardiovascular risk factors in adults with diabetes. Arch Intern Med 2002;162:427-33.
4. American Diabetes Association. Position statement. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2002;25:S33-49.
5. American Diabetes Association. Position statement. Treatment of hypertension in adults with diabetes. Diabetes Care 2002;25:S71-3.
6. Julius S, Majahalme S, Palatini P. Antihypertensive treatment of patients with diabetes and hypertension. Am J Hypertens 2001;14:S310-16.
7. Haffner SM. Management of dyslipidemia in adults with diabetes. Diabetes Care 1998;21:160-78.
8. Raskin P, Ganda OP, Schwartz S, et al. Efficacy and safety of pravastatin in the treatment of patients with type I and type II diabetes mellitus and hypercholesterolemia. Am J Med 1995;99:362-9.
9. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirssin G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart diabetes. Diabetes Care 1997;20:614-20.
10. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type II diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339;4:229-34.
11. Marcelino JJ, Feingold KR. Inadequate treatment with HMG-CoA reductase inhibitors by health care providers. Am J Med 1996;100:605-10.
12. Kaplan NM. Management of hypertension in patients with type 2 diabetes mellitus: Guidelines based on current evidence. Ann Intern Med 2001;135:1079-83.
13. The National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-97.
14. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KMV. A diabetes report card for the United States: Quality of care in the 1990s. Ann Intern Med 2002;136:565-74.
15. American Diabetes Association. Position statement. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1999;S32-41.
16. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-40.
17. The National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment pane II). JAMA 1993; 269:3015-23.
18. Bakris G, Williams M, Dworkin L, et al. Preserving renal function in adults with hypertension and diabetes: A consensus approach. Am J Kid Dis 2000;36:646-61.
19. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1999;22:S5-19.
20. Furberg CD, Psaty BM, Pahor M, Alderman M. Clinical implications of recent findings from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT) and other studies of hypertension. Ann Intern Med 2001;135:1074-8.
21. American Diabetes Association. Position statement. Management of dyslipidemia in adults with diabetes. Diabetes Care 2001;24:S58-61.
22. Cohen MV, Byrne MJ, Levine B, Gutowski T, Adelson R. Low rates of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven CAD. Circulation 1991;83:1294-304.
23. Giles WH, Anda RF, Jones DH, Serdula MK, Merritt RK, DeStefano F. Recent trends in the identification and treatment of high blood cholesterol by physicians: Progress and missed opportunities. JAMA 1993;269:1113-38.
24. Abookire S, Karson A, Fiskio J, Bates D. Use and monitoring of "statin" lipid-lowering drugs compared with guidelines. Arch Intern Med 2001;161:53-8.
25. Hoerger TJ, Bala MB, Bray JW, Wilcosky TC, LaRosa J. Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults. Am J Cardiol 1998;82:61-5.
26. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes. JAMA 2002;287:360-72.
27. American Diabetes Association. Position statement. Aspirin therapy in diabetes. Diabetes Care 1999;22:S60-1.
28. Huang E, Meigs J, Singer D. The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med 2001;111:633-42.
29. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians. Arch Intern Med 2000;160:2281-6.
30. Holmboe ES. Oral antihyperglycemic therapy for type 2 diabetes. JAMA 2002;287:373-6.
31. American Diabetes Association. Position statement. Implications of the United Kingdom prospective diabetes study. Diabetes Care 2002;25:S28-32.